EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibro‐Adipogenic Progenitor Ablation Triggers Muscle Atrophy Through Cell Death‐Induced Inflammation

Yangyi E Luo iD, Young Il Lee iD, Zoe Abe-Teh, Rachel Y Young iD, Lan Wei-LaPierre iD, Elisabeth R Barton iD

Journal of Cachexia, Sarcopenia and Muscle · 2026

DOI: 10.1002/jcsm.70393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2026. Verfasst von Yangyi E Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Inflammation, Muscular Atrophy, Adipogenesis, Stem Cells. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Spinal Muscular Atrophy Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Skeletal muscle mass maintenance involves coordination of myofibers with mononuclear cell populations, including satellite cells, resident macrophages and fibro‐adipogenic progenitors (FAPs). FAPs, identified by surface expression of PDGFRα, are important contributors to muscle homeostasis, as genetic ablation of FAPs induces rapid muscle atrophy. However, mechanisms underlying this response remain poorly understood.

Methods

We utilized tamoxifen‐inducible FAP specific diptheria toxin (DTA) mice ( Pdgfra Cre‐ERT2/+; Rosa26 ^DTA/+ ) to evaluate consequences of FAP deletion, measuring body and muscle mass, and isolated function on the extensor digitorum longus (EDL) and soleus (SOL). Neuromuscular junction (NMJ) patency was assessed via whole‐mount staining, nerve vs. direct muscle stimulated function, and denervation‐responsive expression targeting AchRα/β/γ. Immunofluorescence of muscle sections was used to investigate cellular and morphological changes. RT‐qPCR measured expression of atrogenes, inflammatory chemokines/cytokines, and growth factors in tibialis anterior (TA) muscles. To modulate the immune response, mice were subjected to immune cell depletion, pharmacological Cxcr2 inhibition, or treatment with the anti‐inflammatory steroid Vamorolone (VBP15).

Results

Following tamoxifen administration, FAP density decreased 90%, coupled with a 30% loss of lean mass ( p < 0.001). Isolated contractile measurements showed that FAP‐deleted muscles exhibited 25% reductions in maximal tetanic force in the EDL and SOL, while specific force and vulnerability to contractile damage remained unchanged. Whole‐mount staining revealed preserved NMJ structural integrity, and functional testing showed no differences between nerve and direct muscle stimulation. RT‐qPCR showed no change in genes encoding AchR subunits. Longitudinal body composition tracking revealed that FAP‐deletion‐induced muscle and fat loss occurred during tamoxifen administration and coincided with a 10‐fold increase in the infiltration of macrophages and neutrophils. Robust 10‐ to 150‐fold increases ( p < 0.0001) in chemokine transcript levels was observed soon after FAP deletion but preceded atrogene upregulation ( Trim63, Fbxo32, Sqstm1, Ulk1 ). Ccl2 increased ~80‐fold, Ccl12 ~ 80‐fold, Cxcl1 ~ 50‐fold, and Cxcl2 ~ 50‐fold. While immune cell depletion exacerbated muscle atrophy by worsening mass loss and further increasing atrogene expression 5‐fold, Cxcr2 inhibition or VBP15 treatment restored muscle mass by 15% ( p < 0.01). VBP15 treatment also resulted in a 50% reduction in atrogene expression and a 70% reduction in Cxcl1/2 expression levels.

Conclusions

Our findings demonstrate that FAP deletion results in simple muscle atrophy without affecting muscular contractile properties and NMJ function. The atrophy induced by the loss of FAPs occurs through an inflammation‐mediated, Cxcl1/2‐dependent mechanism, caused by the response to FAP cell death potentially coupled with the absence of FAP actions on the inflammatory environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationMuscular AtrophyAdipogenesisStem CellsAnimalsMiceCell DeathMuscle, Skeletal

Stichwörter der Autor:innen

CXC‐ligandsFAPsinflammationmuscle atrophyneuromuscular junction

Autor:innen und Institutionen

  • Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, Florida, USA.
  • Myology Institute, University of Florida, Gainesville, Florida, USA.
  • Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Computer and Information Science and Engineering, College of Engineering, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Yangyi E Luo, Young Il Lee, Rachel Y Young, Lan Wei-LaPierre, Elisabeth R Barton

Förderung

  • NICHD NIH HHS
  • Spinal Muscular Atrophy Foundation

Zitieren

APA

Luo, Y. E., Lee, Y. I., Abe-Teh, Z., Young, R. Y., Wei-LaPierre, L., & Barton, E. R. (2026). Fibro‐Adipogenic Progenitor Ablation Triggers Muscle Atrophy Through Cell Death‐Induced Inflammation. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70393

Vancouver

Luo YE, Lee YI, Abe-Teh Z, Young RY, Wei-LaPierre L, Barton ER. Fibro‐Adipogenic Progenitor Ablation Triggers Muscle Atrophy Through Cell Death‐Induced Inflammation. Journal of Cachexia, Sarcopenia and Muscle. 2026. doi:10.1002/jcsm.70393

BibTeX
@article{Luo2026,
  author = {Luo, Yangyi E and Lee, Young Il and Abe-Teh, Zoe and Young, Rachel Y and Wei-LaPierre, Lan and Barton, Elisabeth R},
  title = {Fibro‐Adipogenic Progenitor Ablation Triggers Muscle Atrophy Through Cell Death‐Induced Inflammation},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  doi = {10.1002/jcsm.70393}
}
Kostenlos starten →